Various oncogenes and tumour suppressors, such as KRAS, APC, BRAF, TP53, and SMAD4, have been identified by CRC-related studies and may be useful for diagnosing and treating CRC in the future[5,8,9]. The gene discussed is KRAS; the disease is colorectal carcinoma.